Dentsply Sirona Inc. (XRAY)
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against DENTSPLY SIRONA Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / November 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Dentsply (XRAY) International Revenue Performance Explored
Evaluate Dentsply's (XRAY) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against DENTSPLY SIRONA Inc. (XRAY) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / November 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
DENTSPLY SIRONA Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / November 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Bronstein, Gewirtz & Grossman, LLC Is Investigating DENTSPLY SIRONA Inc. (XRAY) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESSWIRE / November 8, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
DENTSPLY SIRONA Inc. (XRAY) Q3 2024 Earnings Call Transcript
DENTSPLY SIRONA Inc. (XRAY) Q3 2024 Earnings Call Transcript
XRAY Q3 Earnings & Revenues Beat Estimates, 2024 Guidance Revised
DENTSPLY SIRONA's third-quarter results showcase strong top-line growth in the Essential Dental Solutions segment. However, the lowered outlook for fiscal 2024 is a cause of concern.
Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demand
Dentsply Sirona Inc. XRAY shares are trading lower on Thursday.
Dentsply (XRAY) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Bronstein, Gewirtz & Grossman, LLC Encourages DENTSPLY SIRONA Inc. (XRAY) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESSWIRE / November 7, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Dentsply International (XRAY) Q3 Earnings and Revenues Beat Estimates
Dentsply International (XRAY) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.49 per share a year ago.
